Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fruquintinib + Paclitaxel in Advanced Gastric Cancer
NCT02415023Phase 2Completed
- Sponsor
- Hutchison MediPharma (HMP)
- Start
- Nov 2014
- Primary completion
- Mar 2017
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fruquintinib in gastric cancer (GC), sponsored by Hutchison MediPharma (HMP). Started Nov 2014; status: completed.
02
Drugs
fruquintinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02415023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02415023.